日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and Immunogenicity of an Andes Virus DNA Vaccine by Needle-Free Injection: A Randomized, Controlled Phase 1 Study

无针注射安第斯病毒DNA疫苗的安全性和免疫原性:一项随机、对照的1期研究

Paulsen, Grant C; Frenck, Robert Jr; Tomashek, Kay M; Alarcon, Rodolfo M; Hensel, Elizabeth; Lowe, Ashley; Brocato, Rebecca L; Kwilas, Steve A; Josleyn, Matthew D; Hooper, Jay W

Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection

从新世界汉坦病毒感染幸存者中分离出的广谱且强效的中和单克隆抗体

Engdahl, Taylor B; Kuzmina, Natalia A; Ronk, Adam J; Mire, Chad E; Hyde, Matthew A; Kose, Nurgun; Josleyn, Matthew D; Sutton, Rachel E; Mehta, Apoorva; Wolters, Rachael M; Lloyd, Nicole M; Valdivieso, Francisca R; Ksiazek, Thomas G; Hooper, Jay W; Bukreyev, Alexander; Crowe, James E Jr

Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure.

在 DNA 疫苗/鹅平台上生产的抗病毒生物制剂,在暴露后给药可保护仓鼠免受汉坦病毒肺综合征的侵害

Haese Nicole, Brocato Rebecca L, Henderson Thomas, Nilles Matthew L, Kwilas Steve A, Josleyn Matthew D, Hammerbeck Christopher D, Schiltz James, Royals Michael, Ballantyne John, Hooper Jay W, Bradley David S